Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ: IOVA )

5.910 +0.150 (+2.60%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Iovance Biotherapeutics's Options: A Look at What the Big Money is Thinking
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
IOVA Stock Earnings: Iovance Biotherapeutics Meets EPS, Misses Revenue for Q1 2024
IOVA stock results show that Iovance Biotherapeutics met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
How Is The Market Feeling About Iovance Biotherapeutics?
Via Benzinga
Got $500? These Hot Growth Stocks Are Screaming Buys Right Now
The time to jump into a red-hot growth prospect is usually right now...before any more investors identify the opportunity. 
Via The Motley Fool
Where Will Iovance Biotherapeutics Stock Be in 5 Years?
Is this rising healthcare stock a good buy right now? 
Via The Motley Fool
Is Iovance Biotherapeutics Stock a Buy Now?
Let's find out if this biotech can keep up its recent momentum. 
Via The Motley Fool
Unpacking the Latest Options Trading Trends in Iovance Biotherapeutics
Via Benzinga
(IOVA) - Analyzing Iovance Biotherapeutics's Short Interest
Via Benzinga
The Top 3 Biotech Stocks to Buy in April 2024
Learn about the top three biotech stocks to take advantage of these companies' promising futures and pharmaceutical advances. 
Via InvestorPlace
3 Millionaire-Maker Biotech Stocks
The risk at these companies is above average, and they're sure to remain volatile. This volatility, however, includes explosively bullish potential. 
Via The Motley Fool
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
Catalysts lie ahead for both of these companies. 
Via The Motley Fool
Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics
These companies are in the early days of their growth stories. 
Via The Motley Fool
2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street
Find out why investment banks up and down Wall Street have big expectations for these stocks. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Spotlight on Iovance Biotherapeutics: Analyzing the Surge in Options Activity
Via Benzinga
Iovance Biotherapeutics: Q4 Earnings Insights
Via Benzinga
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
With investors seeking new opportunities with certain segments appearing stretched, biotech stocks offer a viable canvas. 
Via InvestorPlace
Forget Eli Lilly. Buy This Magnificent Biotech Stock Instead
This company's growth story is about to get moving with gusto. 
Via The Motley Fool
Piper Sandler Maintains Overweight Rating for Iovance Biotherapeutics: Here's What You Need To Know
Via Benzinga
Truist Securities Maintains Buy Rating for Iovance Biotherapeutics: Here's What You Need To Know
Via Benzinga
1 Wall Street Analyst Thinks Iovance Biotherapeutics Stock Is Going to $32. Is It a Buy Around $17?
Its revenue is set to grow, and one of its trials is no longer paused. 
Via The Motley Fool
Iovance Biotherapeutics Stock Has 22% Upside, According to 1 Wall Street Analyst
With its first approval in hand, attention is now on the top line. 
Via The Motley Fool
Iovance Biotherapeutics's Earnings: A Preview
Via Benzinga
Could Iovance Biotherapeutics Stock Help You Become a Millionaire?
Does Iovance Biotherapeutics stock possess enough upside to generate life-changing returns for your portfolio? 
Via The Motley Fool
Why Iovance Biotherapeutics Stock Got Trounced on Thursday
A robust rally ended abruptly with the publication of the company's latest fundamentals. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Iovance Therapeutics Stock Has Skyrocketed Over 100% so Far This Year. Is It Still a Buy?
More gains might be on the way for this high-flying biotech stock. 
Via The Motley Fool
3 Stocks Flashing Recent Insider Buying Signals
One way to spot an opportunity is by paying attention to insider buying stocks. After all, it’s the insiders that know their company. 
Via InvestorPlace
3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024
Find out which under-the-radar biotech stocks have major catalysts on the horizon, and unlock their explosive growth potential. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.